Literature DB >> 17852445

Apoptosis and proliferation differences between CD34+ and CD34- leukemic subpopulations in childhood acute leukemia.

Tatsiana V Shman1, Valery P Savitski, Uladzimir U Fedasenka, Olga V Aleinikova.   

Abstract

In view of the clinical and biological significance of leukemic heterogeneity we studied the efficacy of spontaneous apoptosis and cell cycle distribution in CD34+ and CD34 - leukemic subpopulations. Acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML) leukemic samples with CD34 heterogeneous expression were separated into CD34+ and CD34 - fractions using fluorescence activated cell sorting. Cell cycle distribution, and apoptosis of the sorted subpopulations were estimated. CD34+ leukemic subpopulations had lower ability to apoptosis than that of CD34 - fractions in 6 out of 8 ALL samples and in 4 out of 5 AML samples. CD34+ fractions showed a higher percentage of proliferating cells compared to CD34 - cells in T-lineage ALL. These differences may lead to a more resistant phenotype of one of the subpopulations and reappearance this population in relapse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17852445     DOI: 10.1080/10245330701393758

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  2 in total

1.  Identification of residual leukemic cells by flow cytometry in childhood B-cell precursor acute lymphoblastic leukemia: verification of leukemic state by flow-sorting and molecular/cytogenetic methods.

Authors:  Nina F Øbro; Lars P Ryder; Hans O Madsen; Mette K Andersen; Birgitte Lausen; Henrik Hasle; Kjeld Schmiegelow; Hanne V Marquart
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  CD34 promotes satellite cell motility and entry into proliferation to facilitate efficient skeletal muscle regeneration.

Authors:  Leslie Ann So Alfaro; Sarah A Dick; Ashley L Siegel; Adam S Anonuevo; Kelly M McNagny; Lynn A Megeney; D D W Cornelison; Fabio M V Rossi
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.